Active Ingredient
(in each extended-release tablet)
Guaifenesin USP 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Topco Associates Llc for the product Guaifenesin (NDC 76162-031). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each extended-release tablet)
Guaifenesin USP 1200 mg
Expectorant
Do not use
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
colloidal silicon dioxide, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, and pregelatinised starch (maize)
1-855-274-4122 (Monday – Friday 8:30 AM to 5:00 PM EST)
DISTRIBUTED BY TOPCO ASSOCIATES LLC
ITASCA, IL 60143 ©TOPCO ARHA0825
QUESTIONS? 1-888-423-0139
[email protected] www.topcarebrand.com
MADE IN INDIA
Topcare®
health
NDC 76162-031-56
COMPARE TO THE ACTIVE INGREDIENT
IN MAXIMUM STRENGTH MUCINEX®*
MAXIMUM STRENGTH
Mucus ER
GUAIFENESIN
EXTENDED-RELEASE TABLETS 1200 mg
GUAIFENESIN 1200 mg - EXPECTORANT
RELIEVES CHEST CONGESTION
12
HOUR
For Day or Night
56
EXTENDED-RELEASE TABLETS
* Please review the disclaimer below.